RECRUITINGOBSERVATIONAL
Common and Specific Information From Neuroimaging and Smartphone
Individual Gait Pattern and MRI Lesion Load to Quantify Gait Impairment in MS: A Cross Sectional Study.
About This Trial
Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).
Who May Be Eligible (Plain English)
Inclusion Criteria :
- Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS)
- Over 18 years old /age greater than 18 years
- Patients followed at Nantes university hospital or Rennes university hospital
- Last known EDSS before inclusion ranging from 0 to 6 inclusive/EDSS of 0 to 6 inclusive, prior inclusion
- No relapse within 3 months
- With a Medullar MRI planed as part as usual care
- MRI scan can be performed within a maximum of 4 months after or before the walking test.
- Affiliated person or beneficiary of a social security scheme
Exclusion Criteria :
- Bilateral aid needed to walk
- Women who are pregnant
- Patient having expressed their opposition
- Patient under guardianship or security measure
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria :
* Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS)
* Over 18 years old /age greater than 18 years
* Patients followed at Nantes university hospital or Rennes university hospital
* Last known EDSS before inclusion ranging from 0 to 6 inclusive/EDSS of 0 to 6 inclusive, prior inclusion
* No relapse within 3 months
* With a Medullar MRI planed as part as usual care
* MRI scan can be performed within a maximum of 4 months after or before the walking test.
* Affiliated person or beneficiary of a social security scheme
Exclusion Criteria :
* Bilateral aid needed to walk
* Women who are pregnant
* Patient having expressed their opposition
* Patient under guardianship or security measure
Treatments Being Tested
OTHER
eGait
IMU sensor (as part of eGait device) worn at the hip during T25FW
Locations (1)
Nantes University Hospital
Nantes, Loire-Atlantique, France